CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Shanghai Alebund Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Allink Biotherapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Allist Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Allist Pharmaceuticals Coltd — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Ankang Pharmaceutical Coltd — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Argo Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Ark Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Baiying Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Bao Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Bensen Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Biomabs Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Blueray Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Canming Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Celgen Bio-pharmaceutical Coltd — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Chuangshi Medical Technology (Group) — — —
60
42% 		7/20/2026 View Intelligence
Shanghai Cp Guojian Pharmaceutical 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shanghai Curegene Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai De Novo Pharmatech — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Epimab Biotherapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Euhearing Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai First Song Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Fosun Pharmaceutical Industrial Development — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Fudan-zhangjiang Bio-pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Greenvalley Pharmaceutical 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shanghai Guangsheng Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Haini Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Haiyan Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Helioson Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Hengrui Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Hep Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Hongyitang Biopharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Huaota Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Huilun Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Hutchison Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Jeyou Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Jiatan Pharmatech — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Johnson & Johnson Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Jun Pai Ying Shi Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Juncell Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Juntop Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Juvensis Therapeutics Biotechnology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Jw Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Kaibao Pharmaceutical Coltd 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shanghai Kechow Pharma — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Lanyi Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Longwood Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Mabgen Biopharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Medinno Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Mianyi Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Showing 5351 - 5400 of 6,643 companies